46 related articles for article (PubMed ID: 14639619)
1. Enhanced active targeting via cooperative binding of ligands on liposomes to target receptors.
Sugiyama T; Asai T; Nedachi YM; Katanasaka Y; Shimizu K; Maeda N; Oku N
PLoS One; 2013; 8(6):e67550. PubMed ID: 23840738
[TBL] [Abstract][Full Text] [Related]
2. "Splitting the matrix": intussusceptive angiogenesis meets MT1-MMP.
D'Amico G; Muñoz-Félix JM; Pedrosa AR; Hodivala-Dilke KM
EMBO Mol Med; 2020 Feb; 12(2):e11663. PubMed ID: 31858727
[TBL] [Abstract][Full Text] [Related]
3. MT1-MMP-Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy.
Wei Y; Song S; Duan N; Wang F; Wang Y; Yang Y; Peng C; Li J; Nie D; Zhang X; Guo S; Zhu C; Yu M; Gan Y
Adv Sci (Weinh); 2020 Sep; 7(17):1902746. PubMed ID: 32995113
[TBL] [Abstract][Full Text] [Related]
4. Sapacitabine for cancer.
Liu X; Kantarjian H; Plunkett W
Expert Opin Investig Drugs; 2012 Apr; 21(4):541-55. PubMed ID: 22329458
[TBL] [Abstract][Full Text] [Related]
5. Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.
Hasbum A; Quintanilla J; Jr JAA; Ding MH; Levy A; Chew SA
Future Med Chem; 2021 Feb; 13(4):393-418. PubMed ID: 33399488
[TBL] [Abstract][Full Text] [Related]
6. TargetAntiAngio: A Sequence-Based Tool for the Prediction and Analysis of Anti-Angiogenic Peptides.
Laengsri V; Nantasenamat C; Schaduangrat N; Nuchnoi P; Prachayasittikul V; Shoombuatong W
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212918
[TBL] [Abstract][Full Text] [Related]
7. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.
Man F; Gawne PJ; T M de Rosales R
Adv Drug Deliv Rev; 2019 Mar; 143():134-160. PubMed ID: 31170428
[TBL] [Abstract][Full Text] [Related]
8. Nanopreparations for organelle-specific delivery in cancer.
Biswas S; Torchilin VP
Adv Drug Deliv Rev; 2014 Feb; 66():26-41. PubMed ID: 24270008
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma.
Katanasaka Y; Kodera Y; Kitamura Y; Morimoto T; Tamura T; Koizumi F
Mol Cancer; 2013 Apr; 12():31. PubMed ID: 23617883
[TBL] [Abstract][Full Text] [Related]
10. Molecular targeting of liposomal nanoparticles to tumor microenvironment.
Zhao G; Rodriguez BL
Int J Nanomedicine; 2013; 8():61-71. PubMed ID: 23293520
[TBL] [Abstract][Full Text] [Related]
11. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
Immordino ML; Dosio F; Cattel L
Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
[TBL] [Abstract][Full Text] [Related]
12. Cancer gene therapy targeting angiogenesis: an updated review.
Liu CC; Shen Z; Kung HF; Lin MC
World J Gastroenterol; 2006 Nov; 12(43):6941-8. PubMed ID: 17109514
[TBL] [Abstract][Full Text] [Related]
13. The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices.
Ghersi G; Zhao Q; Salamone M; Yeh Y; Zucker S; Chen WT
Cancer Res; 2006 May; 66(9):4652-61. PubMed ID: 16651416
[TBL] [Abstract][Full Text] [Related]
14. Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging.
Greschus S; Kiessling F; Lichy MP; Moll J; Mueller MM; Savai R; Rose F; Ruppert C; Günther A; Luecke M; Fusenig NE; Semmler W; Traupe H
Neoplasia; 2005 Aug; 7(8):730-40. PubMed ID: 16207475
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic gene therapy of cancer: recent developments.
Tandle A; Blazer DG; Libutti SK
J Transl Med; 2004 Jun; 2(1):22. PubMed ID: 15219236
[TBL] [Abstract][Full Text] [Related]
16. Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase.
Kondo M; Asai T; Katanasaka Y; Sadzuka Y; Tsukada H; Ogino K; Taki T; Baba K; Oku N
Int J Cancer; 2004 Jan; 108(2):301-6. PubMed ID: 14639619
[TBL] [Abstract][Full Text] [Related]
17. Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP-CNDAC.
Asai T; Miyazawa S; Maeda N; Hatanaka K; Katanasaka Y; Shimizu K; Shuto S; Oku N
Cancer Sci; 2008 May; 99(5):1029-33. PubMed ID: 18294280
[TBL] [Abstract][Full Text] [Related]
18. Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.
Asai T; Shimizu K; Kondo M; Kuromi K; Watanabe K; Ogino K; Taki T; Shuto S; Matsuda A; Oku N
FEBS Lett; 2002 Jun; 520(1-3):167-70. PubMed ID: 12044891
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
